Seven Corners Publishes Open Letter to Shareholders of Merrimack Pharmaceuticals Regarding Annual Me
Today Seven Corners Capital published an Open Letter to Shareholders of Merrimack Pharmaceuticals (ticker MACK) Regarding Proposals 4 & 5 Contained in MACK's Definitive Proxy Statement for its 2020 Annual Meeting (scheduled for May 28, 2020). THE LETTER ADVOCATES THAT MACK SHAREHOLDERS VOTE AGAINST PROPOSAL #4 AND FOR PROPOSAL #5 (I.E., IN EACH CASE AGAINST OUR BOARD’S RECOMMENDATIONS). For see a detailed discussion of each of these proposals, please see the PDF of our full l
